Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Schell

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Endocrinology|May 27, 2010
Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita miceAdam R Wende, Jamie Soto, Curtis D Olsen, et al.
Cancer|February 1, 1984
Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trialA U Buzdar, G R Blumenschein, T L Smith, et al.
Scientific Reports|November 23, 2017
The WD40-domain containing protein CORO2B is specifically enriched in glomerular podocytes and regulates the ventral actin cytoskeletonM Rogg, M Yasuda-Yamahara, A Abed, et al.
Science Advances|September 30, 2022
Mitochondrial pyruvate supports lymphoma proliferation by fueling a glutamate pyruvate transaminase 2-dependent glutaminolysis pathwayPeng Wei, Alex J Bott, Ahmad A Cluntun, et al.
American Journal of Epidemiology|May 19, 2023
Translating Predictive Analytics for Public Health Practice: A Case Study of Overdose Prevention in Rhode IslandBennett Allen, Daniel B Neill, Robert C Schell, et al.
Addiction (Abingdon, England)|November 3, 2021
Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population-based, community intervention trialBrandon D L Marshall, Nicole Alexander-Scott, Jesse L Yedinak, et al.
Lancet (London, England)|May 26, 2004
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialDavid W Andrews, Charles B Scott, Paul W Sperduto, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2013
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320Paul W Sperduto, Meihua Wang, H Ian Robins, et al.
Epidemiology (Cambridge, Mass.)|January 5, 2024
PROVIDENT: Development and Validation of a Machine Learning Model to Predict Neighborhood-level Overdose Risk in Rhode IslandBennett Allen, Robert C Schell, Victoria A Jent, et al.
Science (New York, N.Y.)|May 26, 2012
A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humansDaniel K Bricker, Eric B Taylor, John C Schell, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Endocrinology|May 27, 2010
Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita miceAdam R Wende, Jamie Soto, Curtis D Olsen, et al.
Cancer|February 1, 1984
Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trialA U Buzdar, G R Blumenschein, T L Smith, et al.
Scientific Reports|November 23, 2017
The WD40-domain containing protein CORO2B is specifically enriched in glomerular podocytes and regulates the ventral actin cytoskeletonM Rogg, M Yasuda-Yamahara, A Abed, et al.
Science Advances|September 30, 2022
Mitochondrial pyruvate supports lymphoma proliferation by fueling a glutamate pyruvate transaminase 2-dependent glutaminolysis pathwayPeng Wei, Alex J Bott, Ahmad A Cluntun, et al.
American Journal of Epidemiology|May 19, 2023
Translating Predictive Analytics for Public Health Practice: A Case Study of Overdose Prevention in Rhode IslandBennett Allen, Daniel B Neill, Robert C Schell, et al.
Addiction (Abingdon, England)|November 3, 2021
Preventing Overdose Using Information and Data from the Environment (PROVIDENT): protocol for a randomized, population-based, community intervention trialBrandon D L Marshall, Nicole Alexander-Scott, Jesse L Yedinak, et al.
Lancet (London, England)|May 26, 2004
Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trialDavid W Andrews, Charles B Scott, Paul W Sperduto, et al.
International Journal of Radiation Oncology, Biology, Physics|February 9, 2013
A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: Radiation Therapy Oncology Group 0320Paul W Sperduto, Meihua Wang, H Ian Robins, et al.
Epidemiology (Cambridge, Mass.)|January 5, 2024
PROVIDENT: Development and Validation of a Machine Learning Model to Predict Neighborhood-level Overdose Risk in Rhode IslandBennett Allen, Robert C Schell, Victoria A Jent, et al.
Science (New York, N.Y.)|May 26, 2012
A mitochondrial pyruvate carrier required for pyruvate uptake in yeast, Drosophila, and humansDaniel K Bricker, Eric B Taylor, John C Schell, et al.
Pageof 16